NCT07002177 2026-01-07
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Forward Pharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT07292207 2025-12-18
ARCHE
Nagoya City University
Phase 2 Not yet recruiting
NCT04456920 2025-12-02
BIO-PSY
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT05392608 2025-09-17
SEQUEL-Breast
Borstkanker Onderzoek Groep
Phase 2 Active not recruiting
NCT06033092 2025-08-28
TOLERANT
European Institute of Oncology
Phase 2 Active not recruiting
NCT04055493 2025-08-26
ADAPTcycle
West German Study Group
Phase 3 Active not recruiting
NCT05722795 2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA Recruiting
NCT06150898 2025-06-13
KePreSt
Jules Bordet Institute
Phase 2 Recruiting